Feb 28, 2017 | Infectious Diseases
Dr Pieter Ekermans & Dr Xoliswa Poswa
The urine lipoarabinomannan test (U-lam) has been marketed as an adjunct diagnostic modality in HIV-infected patients with severe immunosuppression. The test detects a cell wall component of the Mycobacterium tuberculosis bacterium that is excreted in urine. The lateral flow test format of the test (Determine TM TB-LAM Ag test) is rapid and can be performed directly on urine.
Full Article